83 related articles for article (PubMed ID: 11003614)
1. Hepatocellular carcinoma cell cycle: study of Long-Evans cinnamon rats.
Masaki T; Shiratori Y; Rengifo W; Igarashi K; Matsumoto K; Nishioka M; Hatanaka Y; Omata M
Hepatology; 2000 Oct; 32(4 Pt 1):711-20. PubMed ID: 11003614
[TBL] [Abstract][Full Text] [Related]
2. Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.
Kita Y; Masaki T; Funakoshi F; Yoshida S; Tanaka M; Kurokohchi K; Uchida N; Watanabe S; Matsumoto K; Kuriyama S
Int J Oncol; 2004 May; 24(5):1205-11. PubMed ID: 15067343
[TBL] [Abstract][Full Text] [Related]
3. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
Masaki T; Shiratori Y; Rengifo W; Igarashi K; Yamagata M; Kurokohchi K; Uchida N; Miyauchi Y; Yoshiji H; Watanabe S; Omata M; Kuriyama S
Hepatology; 2003 Mar; 37(3):534-43. PubMed ID: 12601350
[TBL] [Abstract][Full Text] [Related]
4. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
6. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB
Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318
[TBL] [Abstract][Full Text] [Related]
7. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
8. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
9. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.
Masaki T; Okada M; Tokuda M; Shiratori Y; Hatase O; Shirai M; Nishioka M; Omata M
Hepatology; 1999 Feb; 29(2):379-84. PubMed ID: 9918913
[TBL] [Abstract][Full Text] [Related]
10. The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma.
Bahnassy AA; Zekri AR; Loutfy SA; Mohamed WS; Moneim AA; Salem SE; Sheta MM; Omar A; Al-Zawahry H
Exp Mol Pathol; 2011 Oct; 91(2):643-52. PubMed ID: 21801719
[TBL] [Abstract][Full Text] [Related]
11. pp60c-src activation in hepatocellular carcinoma of humans and LEC rats.
Masaki T; Okada M; Shiratori Y; Rengifo W; Matsumoto K; Maeda S; Kato N; Kanai F; Komatsu Y; Nishioka M; Omata M
Hepatology; 1998 May; 27(5):1257-64. PubMed ID: 9581679
[TBL] [Abstract][Full Text] [Related]
12. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
13. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.
Bates S; Bonetta L; MacAllan D; Parry D; Holder A; Dickson C; Peters G
Oncogene; 1994 Jan; 9(1):71-9. PubMed ID: 8302605
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas.
Ohashi R; Gao C; Miyazaki M; Hamazaki K; Tsuji T; Inoue Y; Uemura T; Hirai R; Shimizu N; Namba M
Anticancer Res; 2001; 21(1B):657-62. PubMed ID: 11299822
[TBL] [Abstract][Full Text] [Related]
15. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle regulators during human atrial development.
Kim WH; Joo CU; Ku JH; Ryu CH; Koh KN; Koh GY; Ko JK
Korean J Intern Med; 1998 Jul; 13(2):77-82. PubMed ID: 9735660
[TBL] [Abstract][Full Text] [Related]
17. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
18. Accelerated growth of hepatocytes in association with Up-regulation of cyclin E in transgenic mice expressing the dominant negative form of retinoic acid receptor.
Tsutusmi A; Shiota G; Yamazaki H; Kunisada T; Terada T; Kawasaki H
Biochem Biophys Res Commun; 2000 Nov; 278(1):229-35. PubMed ID: 11071877
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical demonstration of cyclins A, B, D1, D3 and E in hepatocellular carcinomas using tissue microarrays].
Zhu MH; Ni CR; Zhu Z; Li FM; Zhang SM
Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):440-3. PubMed ID: 14633457
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture.
Kawada N; Ikeda K; Seki S; Kuroki T
J Hepatol; 1999 Jun; 30(6):1057-64. PubMed ID: 10406184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
